ICD-10-CM Billable Code

Z22.322

Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus

Clinical Classification Guidelines

Inclusion Terms

  • MRSA colonization

Medical Intelligence & Overview

ICD-10 code Z22.322 refers to individuals who are carriers or suspected carriers of Methicillin-resistant Staphylococcus aureus (MRSA). This designation indicates that a person harbors the bacteria in their body without showing signs of infection, which still poses a risk of transmitting MRSA to others. Understanding carrier status is important for preventing the spread of this resistant bacteria and maintaining public health.

Causes & Symptoms

Clinical Causes: Prolonged or repeated hospitalization, especially in healthcare facilities with high MRSA incidence Close contact with someone infected or colonized with MRSA Use of invasive medical devices like catheters or surgical implants Compromised immune system or underlying health conditions Poor hygiene and sanitation practices Living in crowded or unsanitary conditions

Key Symptoms: Typically asymptomatic — no visible signs of infection Possible minor skin irritation or sores if colonization occurs on the skin Potential for spread to others, especially in healthcare settings

Diagnostic & Treatment

Diagnosis Path: Diagnosis of MRSA carrier status typically involves colonization screening through swab tests of areas like the nose, throat, groin, or infected wound sites. Laboratory analysis identifies the presence of MRSA bacteria. Sometimes, cultures are performed to confirm colonization, especially before surgeries or invasive procedures to reduce infection risk.

Treatment Protocols: Since colonization often does not cause symptoms, treatment may not be necessary for asymptomatic carriers. However, in certain situations, healthcare providers might recommend decolonization strategies such as topical antibiotics or hygiene measures. Strict infection control practices are crucial to prevent transmission, especially in hospitals and long-term care facilities. Routine screening and decolonization protocols are often implemented for healthcare workers and patients at risk.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z22.322 a billable ICD-10 code?
Yes, Z22.322 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z22.322?
Clinical documentation must specify the nature of Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

staphylococcus resistant aureus methicillin carrier suspected